AI portfolio risk
Use-case map, sponsor, expected value, dependencies, criticality and criteria to stop, reframe or move to production.
We use cookies to improve your experience and analyze our site traffic. You can accept, refuse or customize your choices at any time.
To learn more, see our privacy policy
ENTERPRISE AI AUDIT
An executive audit to qualify AI portfolio risk, data maturity, governance, security and production readiness before committing budget, compliance exposure or teams.
Why audit now
Identify AI initiatives that expose core systems, compliance obligations or sensitive data.
Separate opportunities ready for industrialization from ideas that still need evidence.
Give business, data, IT and security leaders a shared basis for decisions.
Accountability frame
NeuroVista provides an independent, structured and actionable assessment. The findings support technical and executive decisions; they do not replace legal, financial, regulatory or certification audits.
Method: targeted interviews, document review, mapping of use cases, data, risks, vendors and production constraints.
Scope: findings, assumptions, unverified areas, ownership and expected evidence are made explicit in the final package.
Accountability: a NeuroVista lead owns the synthesis, audit limitations and prioritized action plan.
The assessment covers portfolio, data, controls and production architecture. The goal is not to promise ROI: it is to reduce uncertainty before an executive decision.
Use-case map, sponsor, expected value, dependencies, criticality and criteria to stop, reframe or move to production.
Decision roles, human validation, model policies, traceability, AI Act/GDPR requirements and legal alignment.
Availability, quality, freshness, lineage, access rights, sensitive data and real preparation effort before modeling.
Prompt exposure, access, secrets, retention, AI vendors, data residency and integration risk.
Observability, drift, evaluations, rollback, monitoring, inference costs and transition from pilot to operated service.
Executive view of risk, technical debt, critical dependencies, security effort and 30/60/90-day path.
Expected outputs
Value / risk / maturity matrix for each AI initiative
Risk register across data, model, security, compliance and production
Readiness scorecards for priority use cases
Limitations note: assumptions, missing evidence and associated ownership
Decision paths: stop, reframe, secure, industrialize
30/60/90-day plan with expected evidence and dependencies
Method
AI portfolio, involved systems, teams, data, vendors, costs and security constraints.
Risk level, evidence level, data maturity, production feasibility and defensible business value.
Prioritized workstreams, go/no-go decisions and minimum conditions to move into production.
Short execution plan, ownership, compliance evidence and operational guardrails.
AI portfolio already started but difficult to read
Executive committee must prioritize AI budgets
CIO or CISO concerned about industrialization
Due diligence before investment, acquisition or partnership
Regulated organization or high sensitive-data exposure
Share the context, constraints and decision level expected. We scope a short, readable and actionable audit.
Contact NeuroVista